18 min listen
CLL highlights at EHA 2023: latest advances with the use of BTK inhibitors
FromVJHemOnc Podcast
ratings:
Length:
14 minutes
Released:
Jun 29, 2023
Format:
Podcast episode
Description
Bruton’s tyrosine kinase (BTK) inhibitors have transformed the treatment landscape of chronic lymphocytic leukemia (CLL), with both covalent and non-covalent...
The post CLL highlights at EHA 2023: latest advances with the use of BTK inhibitors appeared first on VJHemOnc.
The post CLL highlights at EHA 2023: latest advances with the use of BTK inhibitors appeared first on VJHemOnc.
Released:
Jun 29, 2023
Format:
Podcast episode
Titles in the series (100)
MRD testing in multiple myeloma: new technology with promising clinical applications: Determining measurable residual disease (MRD) status is undoubtedly proving to be an effective method of prognostication and measurement of response... by VJHemOnc Podcast